Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
First patient treated in Clarity's therapeutic prostate cancer trial 2022-10-07 21:06
United Imaging Installs Broward County's First uMI 550 at Holy Cross Health in Fort Lauderdale 2022-10-07 00:00
HanAll's Second FcRn Inhibitor HL161ANS to be Added to the Development Program of its Licensed Partner 2022-10-04 19:00
Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Game-changing Versatilities in Human Biochemistry 2022-10-04 14:00
Duality announced the appointment of Dr. Yver as Chairman of SAB 2022-10-03 22:00
DetectedX to Provide Free Access to Radiology Online Learning Platform to Radiology Across Borders to Enhance Global Charity's Teaching Initiatives 2022-10-03 20:00
Estrella Biopharma, Inc., a biopharmaceutical company to Become a Publicly Traded Company Via Merger with TradeUP Acquisition Corp. 2022-10-03 19:27
AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution for the Treatment of Chronic Obstructive Pulmonary Disease 2022-10-03 09:00
Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022 2022-10-01 04:30
Concord Medical Announces Changes in Management 2022-10-01 04:01
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022 2022-09-29 19:00
NeuShen Therapeutics Closes Pre-A Financing with ~$20M 2022-09-29 17:50
Kintor Pharma Announces Publication of Phase Ib Data from Pruxelutamide for AR+ mBC in EJC 2022-09-29 14:22
Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc 2022-09-29 11:32
GC Labs becomes the first Korean laboratory to obtain certification of CDC standardization programs (VDSCP & HoSt) 2022-09-29 08:17
Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications 2022-09-28 21:18
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts 2022-09-28 19:00
Harbour BioMed Announces First Subject Dosed in Phase I Study of Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-09-27 21:40
Neurophth announces first patient dosed in Phase III clinical trial for the gene therapy treatment of LHON 2022-09-27 20:30
Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China 2022-09-27 08:30
1 110 111 112 113 114 432